COMMAND Trial
Early feasibility study of an endovascular BCI in severe paralysis.
Study Design
A single-arm, open-label study (N=6) assessing the safety and efficacy of the Stentrode device implanted via the jugular vein into the superior sagittal sinus.
Primary Endpoints
| Endpoint | Result |
|---|---|
| Device-related SAEs at 12m | 0 events reported (100% safety threshold met) |
| Signal Stability | Maintained decoding accuracy >90% at 1 year. |
Related: Evidence Hub, BCI Guide